Incretin-based therapies have revolutionized the medicalmanagement of type 2 diabetes mellitus (T2DM)in the 21st century. Glucagon-like peptide-1 (GLP-1)suppresses
Obesity and type 2 diabetes mellitus (T2DM) are majorpublic health issues globally over the past few decades.Despite dietary interventions, lifestyle modification